Various safety parameters were followed during the animal and clinical studies and there were no reports of any serious adverse events. Adverse events that were reported by the patients suffering from RRMS were connected to the application site (for example local reaction on the site of application) and time of application (for example facial redness, dryness of the mouth etc.) that were resolved within one hour following application.
All safety parameters, of which there were 70 laboratory and 13 monitored by the specialist of internal medicine, were within the physiological ranges.
